Ubistatins Inhibit Proteasome-Dependent Degradation by Binding the Ubiquitin Chain
Rati Verma(Howard Hughes Medical Institute), Randall W. King(Howard Hughes Medical Institute), Philip Coffino(Howard Hughes Medical Institute), Gregory P. Tochtrop(Howard Hughes Medical Institute), Kathleen M. Sakamoto(Stanford University), David Fushman(Association of Organ Procurement Organizations), Noël R. Peters(Howard Hughes Medical Institute), Raymond J. Deshaies(California Institute of Technology), Mingsheng Zhang(Howard Hughes Medical Institute), Ranjani Varadan(University of Maryland, College Park), Mariapina D’Onofrio(Howard Hughes Medical Institute)
Cited by 194
Related Papers
Polyubiquitin chains: polymeric protein signals
|Current Opinion in Chemical Biology|2004|1k
Solution Structure of the Proapoptotic Molecule BID
|Cell|1999|391
Diverse polyubiquitin interaction properties of ubiquitin-associated domains
|Nature Structural & Molecular Biology|2005|333
Solution Conformation of Lys63-linked Di-ubiquitin Chain Provides Clues to Functional Diversity of Polyubiquitin Signaling
|Journal of Biological Chemistry|2004|325
Reversible inhibitor of p97, DBeQ, impairs both ubiquitin-dependent and autophagic protein clearance pathways
|Proceedings of the National Academy of Sciences|2011|323